Home

JAMES M FRATES

CIK 1235598 · Chief Financial Officer · last filed 2026-03-09

JAMES M FRATES is a Chief Financial Officer who has filed 214 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for AMLX, was dated Mar 9, 2026. Across all open-market trades the lifetime net is −$42.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$20.45M

Companies

3

Total Filings

214

Lifetime Open-Market Net

-$42.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMLX Chief Financial Officer 361,628 $24.19 $8.75M -$3.22M 23 2026-03-09
Sage Therapeutics, Inc. (SAGE) Delisted Director 1,810 $8.68 $15.7K -$4.48M 21 2025-07-31
ALKS SVP, Alks Inc; CFO ALKS 241,828 $48.37 $11.70M -$34.81M 166 2020-05-14

Recent Filings

214 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-09 AMLX Grant (A) +95,990 $0 EDGAR
2026-03-04 AMLX Sell (S) −7,909 -$114.9K EDGAR
2026-03-02 AMLX Notice (144) −7,909 -$114.9K EDGAR
2026-02-04 AMLX Sell (S) −3,557 -$52.1K EDGAR
2026-02-02 AMLX Notice (144) −3,557 -$52.1K EDGAR
2026-01-08 AMLX Sell (S) −3,326 -$37.0K EDGAR
2026-01-06 AMLX Notice (144) −3,326 -$37.0K EDGAR
2025-10-02 AMLX Sell (S) −10,558 -$154.7K EDGAR
2025-07-31 Sage Therapeutics, Inc. (SAGE) Delisted Mixed −2,845 $0 EDGAR
2025-06-13 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 214
Page 1 of 22
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.